What are the patterns of symptoms and risk factors for Long COVID among SARS-CoV-2 infected individuals? medrxivpreprint UUtah UCSF DukeMedSchool nyugrossman symptoms riskfactor longcovid covid COVID19 SARSCoV2
By Bhavana KunkalikarDec 12 2022Reviewed by Danielle Ellis, B.Sc. In a recent study posted to the medRxiv* preprint server, researchers explored the indicators of long coronavirus disease 2019 symptoms.
About the study In the present study, researchers determined whether sociodemographic variables, lifestyles, medical history before COVID-19 infection, or acute COVID-19 features are linked with long COVID. In January 2022 and May 2022, participants who had a positive COVID-19 test over 30 days before were presented with a cross-sectional questionnaire regarding Long COVID Symptoms. Using an unvalidated tool, the survey inquired about the existence, duration, and intensity of Long COVID symptoms.
Additionally, survey respondents were more likely to have received their COVID-19 vaccination before infection and to have experienced comparatively more acute symptoms. The median period since the initial SARS-CoV-2 positive test for individuals who did and did not have long COVID symptoms was 360 days and 129 days, respectively.
Deutschland Neuesten Nachrichten, Deutschland Schlagzeilen
Similar News:Sie können auch ähnliche Nachrichten wie diese lesen, die wir aus anderen Nachrichtenquellen gesammelt haben.
SARS-CoV-1 and SARS-CoV-2 spike proteins utilize different mechanisms to bind to ACE2SARS-CoV-1 and SARS-CoV-2 spike proteins utilize different mechanisms to bind to ACE2 ACE2 Angiotensin Coronavirus COVID MERSCoV SARSCoV2 FrontMicrobiol UTEP HowardU
Weiterlesen »
Beijing eases zero-Covid restrictions on transport to revive economy\n\t\t\tKeep abreast of significant corporate, financial and political developments around the world.\n\t\t\tStay informed and spot emerging risks and opportunities with independent global reporting, expert\n\t\t\tcommentary and analysis you can trust.\n\t\t
Weiterlesen »
The benefit-risk of the mRNA-1273 COVID-19 vaccineThe benefit-risk of the mRNA-1273 COVID-19 vaccine medrxivpreprint US_FDA mRNA vaccine vaccination COVID19 coronavirus covid SARSCoV2
Weiterlesen »
Bioengineered soluble ACE2 for brain protection against SARS-CoV-2 infectionBioengineered soluble ACE2 for brain protection against SARS-CoV-2 infection biorxivpreprint NorthwesternU ChariteBerlin UChicago brain SARSCoV2 ACE2 COVID19 coronavirus covid
Weiterlesen »